Literature DB >> 18251955

Cognitive function in chronic kidney disease.

Magdalena Madero1, Ambreen Gul, Mark J Sarnak.   

Abstract

Chronic kidney disease (CKD) is a growing public health problem. The incidence of kidney failure is rising in all age groups but particularly in older adults. Individuals in all stages of CKD are at higher risk for development of cognitive impairment and this may be a major determinant in their quality of life. Furthermore, cognitive impairment is associated with an increased risk of death in dialysis patients. Cerebrovascular disease is a strong risk factor for development of cognitive impairment and vascular disease is a more likely cause of cognitive impairment than Alzheimer's disease in patients with CKD. Both traditional and nontraditional vascular risk factors are more common in CKD and dialysis patients may also be at risk for cognitive impairment via nonvascular risk factors and the hemodialysis procedure itself. Unfortunately, because risk factors for cognitive impairment in CKD have not been thoroughly ascertained, evaluation of potential treatments has been limited. Given the high prevalence of cognitive impairment in all stages of CKD, additional studies are needed to evaluate potential risk factors and treatments in this vulnerable population.

Entities:  

Mesh:

Year:  2008        PMID: 18251955     DOI: 10.1111/j.1525-139X.2007.00384.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  71 in total

1.  Potential beneficial effects of low molecular weight heparin on cognitive impairment in elderly patients on haemodialysis.

Authors:  Milenka Sain; Vedran Kovacic; Josipa Radic; Dragan Ljutic; Ivo Jelicic
Journal:  Drugs Aging       Date:  2012-01-01       Impact factor: 3.923

2.  Association of CKD with disability in the United States.

Authors:  Laura C Plantinga; Kirsten Johansen; Deidra C Crews; Vahakn B Shahinian; Bruce M Robinson; Rajiv Saran; Nilka Ríos Burrows; Desmond E Williams; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2010-10-30       Impact factor: 8.860

Review 3.  Cognitive impairment in chronic kidney disease: clinical findings, risk factors and consequences for patient care.

Authors:  Dirk M Hermann; Andreas Kribben; Heike Bruck
Journal:  J Neural Transm (Vienna)       Date:  2014-01-23       Impact factor: 3.575

4.  Increased brain iron deposition is a risk factor for brain atrophy in patients with haemodialysis: a combined study of quantitative susceptibility mapping and whole brain volume analysis.

Authors:  Chao Chai; Mengjie Zhang; Miaomiao Long; Zhiqiang Chu; Tong Wang; Lijun Wang; Yu Guo; Shuo Yan; E Mark Haacke; Wen Shen; Shuang Xia
Journal:  Metab Brain Dis       Date:  2015-03-22       Impact factor: 3.584

Review 5.  The assessment of cognitive function in older adult patients with chronic kidney disease: an integrative review.

Authors:  Mary Hannan; Alana Steffen; Lauretta Quinn; Eileen G Collins; Shane A Phillips; Ulf G Bronas
Journal:  J Nephrol       Date:  2018-05-25       Impact factor: 3.902

6.  Risk for cognitive impairment across 22 measures of cognitive ability in early-stage chronic kidney disease.

Authors:  Rachael V Torres; Merrill F Elias; Stephen Seliger; Adam Davey; Michael A Robbins
Journal:  Nephrol Dial Transplant       Date:  2017-02-01       Impact factor: 5.992

Review 7.  Approaches to uremia.

Authors:  Timothy W Meyer; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

8.  Chronic kidney disease, creatinine and cognitive functioning.

Authors:  Merrill F Elias; Penelope K Elias; Stephen L Seliger; Sriram S Narsipur; Gregrory A Dore; Michael A Robbins
Journal:  Nephrol Dial Transplant       Date:  2009-03-18       Impact factor: 5.992

Review 9.  Kidney-brain crosstalk in the acute and chronic setting.

Authors:  Renhua Lu; Matthew C Kiernan; Anne Murray; Mitchell H Rosner; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2015-08-18       Impact factor: 28.314

10.  Association of sleep-disordered breathing with cognitive dysfunction in CKD stages 4-5.

Authors:  Ea Wha Kang; Khaled Abdel-Kader; Jonathan Yabes; Khaleelah Glover; Mark Unruh
Journal:  Am J Kidney Dis       Date:  2012-10-12       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.